05/29/2024
6:19 PM | Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:20 PM | LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:21 PM | MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:21 PM | Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:06 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/07/2024
3:05 PM | Rigel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
7:05 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
4:29 PM | Rigel Pharmaceuticals (Filer)
| Form ARS | |
04/10/2024
3:49 PM | Rigel Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
3:50 PM | Rigel Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
4:04 PM | Rigel Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
3:09 PM | Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:14 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:15 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:15 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:16 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:00 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:30 PM | ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
11:17 AM | MORGAN STANLEY (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G | |
02/06/2024
7:18 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:18 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:18 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:34 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
8:56 AM | Rigel Pharmaceuticals (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/25/2024
8:16 PM | Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
8:17 PM | Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
8:17 PM | Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
8:17 PM | Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:30 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
5:04 AM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:16 PM | Rigel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
3:31 PM | Rigel Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/12/2023
5:45 PM | HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:45 PM | Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:45 PM | LYONS GARY A (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:45 PM | Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:45 PM | Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:45 PM | MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:45 PM | LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Dems have chosen Biden replacement? (Ad) On November 16, 2023…
Joe Biden accidentally revealed the name of the candidate…
Who will replace him in the 2024 presidential election. See who it is HERE. |
06/12/2023
7:21 AM | FMR LLC (Filed by)
Rigel Pharmaceuticals (Subject)
| Form SC 13G/A | |
